About: Design and Characterization of Viral Polypeptide Inhibitors Targeting Newcastle Disease Virus Fusion

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Design and Characterization of Viral Polypeptide Inhibitors Targeting Newcastle Disease Virus Fusion Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Design and Characterization of Viral Polypeptide Inhibitors Targeting Newcastle Disease Virus Fusion
Creator	Tien, Po Gao, George Zhu, Jieqing Liu, Yueyong Jiang, Xiuli
source	Elsevier; Medline; PMC
abstract	Paramyxovirus infections can be detected worldwide with some emerging zoonotic viruses and currently there are no specific therapeutic treatments or vaccines available for many of these diseases. Recent studies have demonstrated that peptides derived from the two heptad repeat regions (HR1 and HR2) of paramyxovirus fusion proteins could be used as inhibitors of virus fusion. The mechanism underlying this activity is in accordance with that of class I virus fusion proteins, of which human immunodeficiency virus (HIV) and influenza virus fusion proteins are members. For class I virus fusion proteins, the HR1 fragment binds to HR2 to form a six-helix bundle with three HR1 fragments forming the central coiled bundle surrounded by three coiled HR2 fragments in the post fusion conformational state (fusion core). It is hypothesized that the introduced exogenous HR1 or HR2 can compete against their endogenous counterparts, which results in fusion inhibition. Using Newcastle disease virus (NDV) as a model, we designed several protein inhibitors, denoted HR212 as well asHR121 and 5-Helix, which could bind the HR1 or HR2 region of fusion protein, respectively. All the proteins were expressed and purified using a GST-fusion expression system in Escherichia coli. The HR212 or GST-HR212 protein, which binds the HR1 peptide in vitro, displayed inhibitory activity against NDV-mediated cell fusion, while the HR121 and 5-Helix proteins, which bind the HR2 peptide in vitro, inhibited virus fusion from the avirulent NDV strain when added before the cleavage of the fusion protein. These results showed that the designed HR212, HR121 or 5-Helix protein could serve as specific antiviral agents. These data provide additional insight into the difference between the virulent and avirulent strains of NDV.
has issue date	2005-12-02(xsd:dateTime)
bibo:doi	10.1016/j.jmb.2005.08.078
bibo:pmid	16253271
has license	els-covid
sha1sum (hex)	2b7cc2e066ab4f8252246b530424d878b260b108
schema:url	https://doi.org/10.1016/j.jmb.2005.08.078
resource representing a document's title	Design and Characterization of Viral Polypeptide Inhibitors Targeting Newcastle Disease Virus Fusion
has PubMed Central identifier	PMC7094301
has PubMed identifier	16253271
schema:publication	Journal of Molecular Biology
resource representing a document's body	covid:2b7cc2e066ab4f8252246b530424d878b260b108#body_text
is schema:about of	named entity 'bundle' named entity 'strain' named entity 'Elsevier' named entity 'viruses' named entity 'NDV' »more»

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software